上気道感染症治療の世界市場 2024-2028

概要

上気道感染症治療市場は、2023年から2028年にかけて26億6,115万米ドル、予測期間中のCAGRは4.21%で成長すると予測されています。

当レポートでは、上気道感染症治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、上気道感染症の罹患率および有病率の上昇、有利な医薬品パイプライン、市販薬の需要増加が牽引しています。

本調査では、今後数年間の上気道感染症治療市場成長を牽引する主要因の1つとして、生物製剤の台頭を挙げています。また、上気道感染症を治療するドラッグデリバリー機器の開拓や治療オプションの技術的進歩は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 上気道感染症治療の世界市場 2018-2022
• タイプセグメント分析 2018-2022
• 流通チャネルセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 抗生物質：市場規模と予測 2023-2028
• NSAIDと鼻うっ血除去薬：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 2023-2028
• 小売薬局：市場規模と予測 2023-2028
• オンライン薬局：市場規模と予測 2023-2028
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AstraZeneca Plc
• CSL Ltd.
• GlaxoSmithKline Plc
• MD Total Care LLC.
• Medtronic Plc
• Merck and Co. Inc.
• Novartis AG
• Parkway Holdings Ltd.
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• The Cleveland Clinic Foundation
• Yashoda Hospitals

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global upper respiratory tract infection treatment market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on NSAIDs and nasal decongestants - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on NSAIDs and nasal decongestants - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on NSAIDs and nasal decongestants - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on NSAIDs and nasal decongestants - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Type ($ million)
• Exhibits47: Data Table on Market opportunity by Type ($ million)
• Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Distribution Channel
• Exhibits51: Data Table on Comparison by Distribution Channel
• Exhibits52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibits64: Market opportunity by Distribution Channel ($ million)
• Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ million)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits109: Impact of drivers and challenges in 2023 and 2028
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: AstraZeneca Plc - Overview
• Exhibits116: AstraZeneca Plc - Product / Service
• Exhibits117: AstraZeneca Plc - Key news
• Exhibits118: AstraZeneca Plc - Key offerings
• Exhibits119: CSL Ltd. - Overview
• Exhibits120: CSL Ltd. - Business segments
• Exhibits121: CSL Ltd. - Key offerings
• Exhibits122: CSL Ltd. - Segment focus
• Exhibits123: GlaxoSmithKline Plc - Overview
• Exhibits124: GlaxoSmithKline Plc - Business segments
• Exhibits125: GlaxoSmithKline Plc - Key news
• Exhibits126: GlaxoSmithKline Plc - Key offerings
• Exhibits127: GlaxoSmithKline Plc - Segment focus
• Exhibits128: MD Total Care LLC. - Overview
• Exhibits129: MD Total Care LLC. - Product / Service
• Exhibits130: MD Total Care LLC. - Key offerings
• Exhibits131: Medtronic Plc - Overview
• Exhibits132: Medtronic Plc - Business segments
• Exhibits133: Medtronic Plc - Key news
• Exhibits134: Medtronic Plc - Key offerings
• Exhibits135: Medtronic Plc - Segment focus
• Exhibits136: Merck and Co. Inc. - Overview
• Exhibits137: Merck and Co. Inc. - Business segments
• Exhibits138: Merck and Co. Inc. - Key news
• Exhibits139: Merck and Co. Inc. - Key offerings
• Exhibits140: Merck and Co. Inc. - Segment focus
• Exhibits141: Novartis AG - Overview
• Exhibits142: Novartis AG - Business segments
• Exhibits143: Novartis AG - Key offerings
• Exhibits144: Novartis AG - Segment focus
• Exhibits145: Parkway Holdings Ltd. - Overview
• Exhibits146: Parkway Holdings Ltd. - Product / Service
• Exhibits147: Parkway Holdings Ltd. - Key offerings
• Exhibits148: Pfizer Inc. - Overview
• Exhibits149: Pfizer Inc. - Product / Service
• Exhibits150: Pfizer Inc. - Key news
• Exhibits151: Pfizer Inc. - Key offerings
• Exhibits152: Regeneron Pharmaceuticals Inc. - Overview
• Exhibits153: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibits154: Regeneron Pharmaceuticals Inc. - Key offerings
• Exhibits155: Sanofi - Overview
• Exhibits156: Sanofi - Business segments
• Exhibits157: Sanofi - Key news
• Exhibits158: Sanofi - Key offerings
• Exhibits159: Sanofi - Segment focus
• Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits165: The Cleveland Clinic Foundation - Overview
• Exhibits166: The Cleveland Clinic Foundation - Product / Service
• Exhibits167: The Cleveland Clinic Foundation - Key offerings
• Exhibits168: Yashoda Hospitals - Overview
• Exhibits169: Yashoda Hospitals - Product / Service
• Exhibits170: Yashoda Hospitals - Key offerings
• Exhibits171: Inclusions checklist
• Exhibits172: Exclusions checklist
• Exhibits173: Currency conversion rates for US$
• Exhibits174: Research methodology
• Exhibits175: Validation techniques employed for market sizing
• Exhibits176: Information sources
• Exhibits177: List of abbreviations

Abstract

The upper respiratory tract infection treatment market is forecasted to grow by USD 2,661.15 mn during 2023-2028, accelerating at a CAGR of 4.21% during the forecast period. The report on the upper respiratory tract infection treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence and prevalence of upper respiratory tract infections, favorable drug pipeline, and rising demand for over-the-counter drugs.

Technavio's upper respiratory tract infection treatment market is segmented as below:

By Type

• Antibiotics
• NSAIDs and nasal decongestants
• Others

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of biologics as one of the prime reasons driving the upper respiratory tract infection treatment market growth during the next few years. Also, development of drug delivery devices to treat upper respiratory tract infections and technological advancements in treatment options will lead to sizable demand in the market.

The report on the upper respiratory tract infection treatment market covers the following areas:

• Upper respiratory tract infection treatment market sizing
• Upper respiratory tract infection treatment market forecast
• Upper respiratory tract infection treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading upper respiratory tract infection treatment market vendors that include AstraZeneca Plc, CSL Ltd., GlaxoSmithKline Plc, MD Total Care LLC., Medtronic Plc, Merck and Co. Inc., Novartis AG, Parkway Holdings Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, Teva Pharmaceutical Industries Ltd., The Cleveland Clinic Foundation, and Yashoda Hospitals. Also, the upper respiratory tract infection treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global upper respiratory tract infection treatment market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global upper respiratory tract infection treatment market 2018 - 2022 ($ million)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Antibiotics - Market size and forecast 2023-2028
• Exhibit 34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
• 6.4 NSAIDs and nasal decongestants - Market size and forecast 2023-2028
• Exhibit 38: Chart on NSAIDs and nasal decongestants - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on NSAIDs and nasal decongestants - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on NSAIDs and nasal decongestants - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on NSAIDs and nasal decongestants - Year-over-year growth 2023-2028 (%)
• 6.5 Others - Market size and forecast 2023-2028
• Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
• Exhibit 46: Market opportunity by Type ($ million)
• Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 50: Chart on Comparison by Distribution Channel
• Exhibit 51: Data Table on Comparison by Distribution Channel
• 7.3 Hospital pharmacies - Market size and forecast 2023-2028
• Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• 7.4 Retail pharmacies - Market size and forecast 2023-2028
• Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• 7.5 Online pharmacies - Market size and forecast 2023-2028
• Exhibit 60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 64: Market opportunity by Distribution Channel ($ million)
• Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
• Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
• Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 AstraZeneca Plc
• Exhibit 115: AstraZeneca Plc - Overview
• Exhibit 116: AstraZeneca Plc - Product / Service
• Exhibit 117: AstraZeneca Plc - Key news
• Exhibit 118: AstraZeneca Plc - Key offerings
• 12.4 CSL Ltd.
• Exhibit 119: CSL Ltd. - Overview
• Exhibit 120: CSL Ltd. - Business segments
• Exhibit 121: CSL Ltd. - Key offerings
• Exhibit 122: CSL Ltd. - Segment focus
• 12.5 GlaxoSmithKline Plc
• Exhibit 123: GlaxoSmithKline Plc - Overview
• Exhibit 124: GlaxoSmithKline Plc - Business segments
• Exhibit 125: GlaxoSmithKline Plc - Key news
• Exhibit 126: GlaxoSmithKline Plc - Key offerings
• Exhibit 127: GlaxoSmithKline Plc - Segment focus
• 12.6 MD Total Care LLC.
• Exhibit 128: MD Total Care LLC. - Overview
• Exhibit 129: MD Total Care LLC. - Product / Service
• Exhibit 130: MD Total Care LLC. - Key offerings
• 12.7 Medtronic Plc
• Exhibit 131: Medtronic Plc - Overview
• Exhibit 132: Medtronic Plc - Business segments
• Exhibit 133: Medtronic Plc - Key news
• Exhibit 134: Medtronic Plc - Key offerings
• Exhibit 135: Medtronic Plc - Segment focus
• 12.8 Merck and Co. Inc.
• Exhibit 136: Merck and Co. Inc. - Overview
• Exhibit 137: Merck and Co. Inc. - Business segments
• Exhibit 138: Merck and Co. Inc. - Key news
• Exhibit 139: Merck and Co. Inc. - Key offerings
• Exhibit 140: Merck and Co. Inc. - Segment focus
• 12.9 Novartis AG
• Exhibit 141: Novartis AG - Overview
• Exhibit 142: Novartis AG - Business segments
• Exhibit 143: Novartis AG - Key offerings
• Exhibit 144: Novartis AG - Segment focus
• 12.10 Parkway Holdings Ltd.
• Exhibit 145: Parkway Holdings Ltd. - Overview
• Exhibit 146: Parkway Holdings Ltd. - Product / Service
• Exhibit 147: Parkway Holdings Ltd. - Key offerings
• 12.11 Pfizer Inc.
• Exhibit 148: Pfizer Inc. - Overview
• Exhibit 149: Pfizer Inc. - Product / Service
• Exhibit 150: Pfizer Inc. - Key news
• Exhibit 151: Pfizer Inc. - Key offerings
• 12.12 Regeneron Pharmaceuticals Inc.
• Exhibit 152: Regeneron Pharmaceuticals Inc. - Overview
• Exhibit 153: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibit 154: Regeneron Pharmaceuticals Inc. - Key offerings
• 12.13 Sanofi
• Exhibit 155: Sanofi - Overview
• Exhibit 156: Sanofi - Business segments
• Exhibit 157: Sanofi - Key news
• Exhibit 158: Sanofi - Key offerings
• Exhibit 159: Sanofi - Segment focus
• 12.14 Teva Pharmaceutical Industries Ltd.
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.15 The Cleveland Clinic Foundation
• Exhibit 165: The Cleveland Clinic Foundation - Overview
• Exhibit 166: The Cleveland Clinic Foundation - Product / Service
• Exhibit 167: The Cleveland Clinic Foundation - Key offerings
• 12.16 Yashoda Hospitals
• Exhibit 168: Yashoda Hospitals - Overview
• Exhibit 169: Yashoda Hospitals - Product / Service
• Exhibit 170: Yashoda Hospitals - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 171: Inclusions checklist
• Exhibit 172: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 173: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 174: Research methodology
• Exhibit 175: Validation techniques employed for market sizing
• Exhibit 176: Information sources
• 13.5 List of abbreviations
• Exhibit 177: List of abbreviations